Ethacid

Etamsylate acts on the first step of hemostasis by improving platelet adhesiveness and restoring capillary resistance. It prevents the break down of the capillary wall by its anti-hyaluronidase activity and inhibits prostacycline synthetase which is a powerful vasodilator. It also augments fibrin formation by increasing the generation of thromboplastin and helps in stable fibrin clot formation.

Category:
Haemostatic
Indication:
Menorrhahagia, Metrorrhagia, DUB, Post-Partum Haemorrhage, IUCD induced menorrhagia, bleeding haemorrhoids, Epistaxis, Prostatic surgery, tooth extraction, Tonsillectomy.

Drug Composition:
Each uncoated tablet contains 250 mg & 500 mg etamsylate Injection ampoule: Each 2ml ampoule contains 250 mg Etamsylate.

Dosage:
1 Tablet TID and 250-500 mg I.M / I.V every 4-6 Hourly till bleeding Persist.

Contraindications:
Pregnancy, hypersensitivity and porphyria (a blood disorder).

Precautions:
Patients with history of coeliac disease, during pregnancy and breastfeeding.

This product is currently only available in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.

Stadmed Private Limited
P: +91 247-40-650/651/653
contact@stadmed-global.com